Genomic and Transcriptomic Predictors of Response from Stereotactic Body Radiation Therapy in Patients with Oligoprogressive Renal Cell Carcinoma.

Saved in:
Bibliographic Details
Title: Genomic and Transcriptomic Predictors of Response from Stereotactic Body Radiation Therapy in Patients with Oligoprogressive Renal Cell Carcinoma.
Authors: Zengin ZB; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Govindarajan A; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Salgia N; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Sayegh N; Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Tripathi N; Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Muddasani R; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Chehrazi-Raffle A; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Feng M; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Mercier BD; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Ladbury C; Department of Radiation Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Hao C; Department of Radiation Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Salgia S; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Chawla N; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Meza L; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Malhotra J; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Dizman N; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Hsu J; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Castro DV; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Barragan-Carrillo R; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Ebrahimi H; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Philip EJ; University of California-San Francisco, San Francisco, CA, USA., Chang M; Kerk Kerkorian School of Medicine at UNLV, Las Vegas, NV, USA., Zhang J; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Byron S; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Lyou Y; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Dorff T; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Pal SK; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address: spal@coh.org., Dandapani S; Department of Radiation Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address: sdandapani@coh.org.
Source: European urology oncology [Eur Urol Oncol] 2023 Aug; Vol. 6 (4), pp. 447-450. Date of Electronic Publication: 2023 Jan 04.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2588-9311
DOI:10.1016/j.euo.2022.11.006